Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-02-27

FDA Approved: VOCABRIA — Supplemental Application (ViiV Healthcare Company)

View source ↗

Summary

FDA approved a supplemental application for VOCABRIA (cabotegravir sodium) filed by ViiV Healthcare Company. The action updates the labeling to support the appr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VOCABRIA (cabotegravir sodium)

Snippet

SUPPL AP for VOCABRIA (CABOTEGRAVIR SODIUM)